Eckert & Ziegler

(IN BRIEF) Eckert & Ziegler has secured MDR certification for its Ru-106 eye applicators, ensuring continued availability of a critical treatment for eye cancer patients in the EU. The devices, used in brachytherapy procedures for conditions such as uveal melanoma … Read the full press release →

(IN BRIEF) Eckert & Ziegler SE and Molecular Partners AG have entered into a partnership to develop and potentially manufacture DARPin-based radiopharmaceutical therapies for cancer treatment. Eckert & Ziegler will provide development services for Radio-DARPins using Actinium-225 and Lutetium-177 isotopes, … Read the full press release →

(IN BRIEF) Eckert & Ziegler and the Nuclear Physics Institute of the Czech Academy of Sciences have scaled up production of the critical medical isotope Actinium-225, moving from development into larger-scale manufacturing at facilities in Řež and Braunschweig. The expansion … Read the full press release →